These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34877641)

  • 21. Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review.
    Kassianos G; Barasheed O; Abbing-Karahagopian V; Khalaf M; Ozturk S; Banzhoff A; Badur S
    Infect Dis Ther; 2023 Sep; 12(9):2193-2219. PubMed ID: 37428339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The genomic epidemiology of
    Leong LEX; Coldbeck-Shackley RC; McMillan M; Bratcher HB; Turra M; Lawrence A; Kahler C; Maiden MCJ; Rogers GB; Marshall H
    Lancet Reg Health West Pac; 2024 Feb; 43():100966. PubMed ID: 38169944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and economic burden of invasive meningococcal disease: Evidence from a large German claims database.
    Huang L; Heuer OD; Janßen S; Häckl D; Schmedt N
    PLoS One; 2020; 15(1):e0228020. PubMed ID: 31990941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AMEND study protocol: a case-control study to assess the long-term impact of invasive meningococcal disease in Australian adolescents and young adults.
    Marshall H; McMillan M; Wang B; Booy R; Afzali H; Buttery J; Blyth CC; Richmond P; Shaw D; Gordon D; Barton B
    BMJ Open; 2019 Dec; 9(12):e032583. PubMed ID: 31888931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Diverse Spectrum of Invasive Meningococcal Disease in Pediatric and Adolescent Patients: Narrative Review of Cases and Case Series.
    Bobde S; Sohn WY; Bekkat-Berkani R; Banzhoff A; Cavounidis A; Dinleyici EC; Rodriguez WC; Ninis N
    Infect Dis Ther; 2024 Feb; 13(2):251-271. PubMed ID: 38285269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meningococcal Vaccinations.
    Crum-Cianflone N; Sullivan E
    Infect Dis Ther; 2016 Jun; 5(2):89-112. PubMed ID: 27086142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocol.
    Marshall H; Ward J; Wang B; Andraweera P; McMillan M; Flood L; Bell C; Sisnowski J; Krause V; Webby R; Childs E; Gunathilake M; Egoroff N; Leong L; Lawrence A; Baird R; Freeman K; Menouhos D; Whiley DM; Karnon J; van Hal S; Lahra MM
    BMJ Open; 2024 May; 14(5):e079144. PubMed ID: 38719318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meningococcal serogroup B disease in Turkey: a guess or reality?
    Bakir M
    Hum Vaccin Immunother; 2014; 10(6):1721-4. PubMed ID: 24637878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantifying Stated Preferences for Meningococcal Vaccines Among Adolescents/Young Adults and Parents of Adolescents in the United States: A Discrete Choice Experiment.
    Begum S; Cabrera ES; Restrepo OH; Burman C; Sohn WY; Kuylen E; Shah H; Kocaata Z
    Infect Dis Ther; 2024 Jul; ():. PubMed ID: 39044053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive Disease Due to
    Stein-Zamir C; Shoob H; Abramson N; Valinsky L; Jaffe J; Maimoun D; Amit S; Davidovich-Cohen M
    Microorganisms; 2023 Aug; 11(9):. PubMed ID: 37764056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of Invasive Meningococcal Disease in Colombia: A Retrospective Surveillance Database Analysis.
    Coronell-Rodriguez W; Caceres DC; Cintra O; Guzman-Holst A
    Infect Dis Ther; 2023 Dec; 12(12):2709-2724. PubMed ID: 37966702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Invasive Meningococcal Disease in Preterm Infants.
    Calvert A; Campbell H; Heath PT; Jones CE; Le Doare K; Mensah A; Ladhani S
    Open Forum Infect Dis; 2024 Apr; 11(4):ofae164. PubMed ID: 38665170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of 4CMenB vaccination against gonorrhea: importance of dosing schedule, vaccine sentiment, targeting strategy, and duration of protection.
    Nikitin D; Whittles LK; Imai-Eaton JW; White PJ
    J Infect Dis; 2024 Apr; ():. PubMed ID: 38630583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and Prevention of Invasive Meningococcal Disease in Global Mass Gathering Events.
    Muttalif AR; Presa JV; Haridy H; Gamil A; Serra LC; Cané A
    Infect Dis Ther; 2019 Dec; 8(4):569-579. PubMed ID: 31471813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lifecycle model-based evaluation of infant 4CMenB vaccination in the UK.
    Sevilla JP; Tortorice D; Kantor D; Regan J; Meszaros KH; Beck EC; Begum N; Bloom DE
    Eur J Health Econ; 2024 Jan; ():. PubMed ID: 38182698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of gonorrhoea in the UK.
    Ladhani SN; White PJ; Campbell H; Mandal S; Borrow R; Andrews N; Bhopal S; Saunders J; Mohammed H; Drisdale-Gordon L; Callan E; Sinka K; Folkard K; Fifer H; Ramsay ME
    Lancet Infect Dis; 2024 Mar; ():. PubMed ID: 38521080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meningococcal Disease Outbreaks: A Moving Target and a Case for Routine Preventative Vaccination.
    Soumahoro L; Abitbol V; Vicic N; Bekkat-Berkani R; Safadi MAP
    Infect Dis Ther; 2021 Dec; 10(4):1949-1988. PubMed ID: 34379309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Overview of Meningococcal Disease's Recent Diagnostic and Treatment Model.
    Chhabria D; Anjankar A
    Cureus; 2023 Nov; 15(11):e48509. PubMed ID: 38073961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on invasive meningococcal vaccination for Canadian children and youth.
    Robinson JL
    Paediatr Child Health; 2018 Feb; 23(1):e1-e4. PubMed ID: 29479282
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.